GRIN2D and cancer: Using a cohort of 3899 samples with 10 cancer types, Sharma, et al. [13] adopted a bottom-up approach to quantify the effects of gene expression variations and identified novel recurrent regulatory mutations influencing known cancer genes, such as GRIN2D and NKX2-1, in multiple cancer types.